O-twist marker for marking breast cancer under neoadjuvant chemotherapy - First results;Einsatz des O-twist-markers zur lokalisation von mammakarzinomen unter neoadjuvanter chemotherapie - Erste ergebnisse

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 179, Issue 10, 2007, Pages 1055-1060

  Viehweg, Petra ^a   Fabel, K ^a   Petzold, A ^a   Friedrich, K ^a   Laniado, M ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Biopsy; Breast; Chemotherapy; Ultrasound

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL;

ADJUVANT CHEMOTHERAPY; ARTICLE; BREAST CANCER; CANCER LOCALIZATION; DEVICE; ECHOGRAPHY; HUMAN; MAMMOGRAPHY; MULTIPLE CYCLE TREATMENT; PATIENT MONITORING; PRIORITY JOURNAL; TUMOR BIOPSY;

ADULT; ALLOYS; BIOCOMPATIBLE MATERIALS; BIOPSY; BREAST; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAMMOGRAPHY; MIDDLE AGED; MONITORING, PHYSIOLOGIC; NEOADJUVANT THERAPY; TREATMENT OUTCOME; ULTRASONOGRAPHY, MAMMARY;

EID: 35348986957     PISSN: 14389029     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-963193     Document Type: Article

References (24)

1. Alassas M, Chu Q, Burton G et al. Neoadjuvant chemotherapy in stage III breast cancer. Am Surg 2005; 71: 487-492
2. Hanrahan EO, Hennessy BT, Valero V. Neoadjuvant systemic therapy for breast cancer: an overview and review of recent clinical trials. Expert Opin Pharmacother 2005; 6: 1477-1491
3. Cleator SJ, Makris A, Ashley SE et al. Good clinical response of breast cancers to neoadjuvant chemoendocrine therapy is improved with overall survival. Ann Oncol 2005; 16: 267-272
4. Kaufmann M, Hortobagyi GN, Goldhirsch A et al. Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update. J Clin Oncol 2006; 24: 1940-1949
5. El Khoury C, Servois V, Thibault F et al. MR quantification of the washout changes in breast tumor under preoperative chemotherapy: feasibility and preliminary results. AJR 2005; 184: 1499-1504
6. Martinich L, Montemurro F, De Rosa G et al. Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging. Breast Cancer Res Treat 2004; 83: 67-76
7. Partridge SC, Gibbs JE, Lu Y et al. Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. AJR 1979; 2002: 1193-1199
8. Yeh E, Slanetz P, Kopans DB et al. Prospective comparison of mammography, sonography and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. AJR 2005; 184: 868-877
9. Kwong MS, Chung GG, Horvath LJ et al. Postchemotherapy MRI overestimates residual disease compared with histopathology in responders to neoadjuvant therapy for locally advanced breast cancer. Cancer J 2006; 12: 212-221
10. Rieber A, Brahms HJ, Gabelmann A et al. Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy. Eur Radiol 2002; 12: 1711-1719
11. Rosen EL, Blackwell KL, Baker JA. Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. AJR 2003; 181: 1275-1282
12. Baron LF, Baron PL, Ackerman SJ et al. Sonographically guided clip placement facilitates localization of breast cancer after neoadjuvant chemotherapy. AJR 2000; 174: 539-540
13. Dash N, Chafin SH, Johnson RR et al. Usefulness of tissue marker clips in patients undergoing neoadjuvant chemotherapy for breast cancer. AJR 1999; 173: 911-917
14. Schulz-Wendtland R, Heywang-Köbrunner SH, Aichinger U et al. Verbessert die Clipmarkierung im Rahmen der sonographischen oder stereotaktischen Brustbiopsie die Verlaufsbeurteilung kleiner Mammaläsionen und Lokalisation von Tumoren nach Chemotherapie? Fortschr Röntgenstr 2002; 174: 620-624
15. Sittek H, Heske N, Kessler M et al. O-Twist-Marker zur postinterventionellen Markierung in der Bildgebung suspekter Mammaläsionen. Radiologe 2005; 45: 223-229
16. Fischer T, Filimonow S, Hamm B et al. Dignitätsbeurteilung mammasonografischer Herde mittels dreidimensionaler Darstellung. Fortschr Röntgenstr 2006; 178: 1224-1234
17. Therasse P, Eisenhauer EA, Verweij J. RECIST revisited: a review of validation studies on tumour assessment. EUR J cancer 2006; 42: 1031-1309
18. Junkermann H, von Fournier D. Bildgebende Verfahren zur Beurteilung des Ansprechens des Mammakarzinoms auf eine präoperative Chemotherapie. Radiologe 1997; 37: 726-732
19. Obenauer S, Grabbe E, Knollmann F. Stellenwert der MR-gestützten Lokalisation und Biopsie von Brustläsionen. Fortschr Röntgenstr 2006; 178: 4777-483
20. Perlet C, Sittek H, Reiser M. Clipmarkierung nach MRT-gestützter Vakuumbiopsie der Mamma. Radiologe 2005; 45: 230-236
21. Birdwell RL, Jackman RJ. Clip or marker migration 5-10 weeks after stereotactic 11-gauge vacuum-assisted breast biopsy: report of two cases. Radiology 2003; 229: 541-544
22. Burnside ES, Sohlich RE, Sickles EA. Movement of a biopsy-site marker clip after completion of stereotactic directional vacuum-assisted breast biopsy: case report. Radiology 2001; 221: 504-507
23. Eserman LE, Cura MA, Da Costa D. Recognizing pitfalls in early and late migration of clip markers after imaging-guided directional vacuum-assisted biopsy. Radiographics 2004; 24: 147-156
24. Philpotts LE, Lee CH. Clip migration after 11-gauge vacuum-assisted stereotactic breast biopsy: case report. Radiology 2002; 222: 794-796